More News

05 Jan 2007 Oscient Pharmaceuticals and Menarini Group Enter into European Commercialization Agreement for FACTIVE Tablets
05 Jan 2007 Sunesis Out-Licenses LFA-1 Program to SARcode Corporation
05 Jan 2007 Ecopia Announces Agreement with Caprion to Combine Their Businesses and Launch a $30 Million Private Placement
05 Jan 2007 BioAxone Therapeutic Licenses Phase II Spinal Cord Injury Drug Cethrin(R) to Boston Life Sciences
05 Jan 2007 AVEO acquires Clinical Stage Anti-Cancer Compound from Kirin
05 Jan 2007 Raven Biotechnologies, Inc. And Wyeth (WYE) Partner To Evaluate And Develop
04 Jan 2007 Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure
04 Jan 2007 Sembiosys To Proceed With Abbreviated Regulatory Path For Plant- Produced Insulin After Meeting With The FDA
04 Jan 2007 Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R)
04 Jan 2007 Gentium Acquires Italian Defibrotide Marketing Rights from Crinos
04 Jan 2007 DURECT Starts Phase II Dosing for TRANSDUR(TM)-Bupivacaine (DUR-843)
04 Jan 2007 Five Prime enters Osteoarthritis and Pulmonary Fibrosis Collaboration with Centocor
03 Jan 2007 Galapagos expands and extends drug discovery collaboration with Amgen into 2008
03 Jan 2007 Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncology Compound
03 Jan 2007 Ranbaxy Granted Final Usfda Approval To Manufacture And Market Atenolol Tablets
03 Jan 2007 Lupin Pharmaceuticals, Inc. Announces Tentative Approval Of Generic ZOLOFT(R)

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top